Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEA Antikörper

CEA Reaktivität: Human WB, IHC, FACS, IHC (p), ICC, IHC (fro) Wirt: Maus Monoclonal PARLAM 4 unconjugated
Produktnummer ABIN335404
  • Target Alle CEA Antikörper anzeigen
    CEA (Carcinoembryonic Antigen Gene Family (CEA))
    Reaktivität
    • 119
    • 11
    • 3
    • 3
    • 1
    Human
    Wirt
    • 83
    • 46
    • 3
    • 1
    • 1
    Maus
    Klonalität
    • 93
    • 37
    • 3
    Monoklonal
    Konjugat
    • 57
    • 14
    • 9
    • 6
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser CEA Antikörper ist unkonjugiert
    Applikation
    • 50
    • 38
    • 34
    • 27
    • 27
    • 22
    • 16
    • 13
    • 13
    • 8
    • 8
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Spezifität
    Human.
    Immunogen
    PARLAM 4 is a mouse monoclonal IgG1 antibody derived by fusion of Sp 2/0 Ag 14 mouse myeloma cells with spleen cells from a BABL/c mouse immunized with isolated human CEA. The immunogen has been isolated from human colonic carcinoma cells.
    Klon
    PARLAM 4
    Isotyp
    IgG1
    Top Product
    Discover our top product CEA Primärantikörper
  • Applikationshinweise
    Most polyclonal CEA antisera show cross-reactivity with related antigens such as biliary glycoprotein (BGP) and non-specific cross-reacting antigen 1/11 (NCA). PARLAM 4 does not show cross reactivity, neither with BGP nor with NCA. In immunoblotting the antibody recognizes a single band of 180 kD.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Lagerung
    4 °C
  • Taal, Hageman, Delemarre, Bonfrèr, den Hartog Jager: "Metastatic ovarian or colonic cancer: a clinical challenge." in: European journal of cancer (Oxford, England : 1990), Vol. 28, Issue 2-3, pp. 394-9, (1992) (PubMed).

    Henzen-Logmans, Schipper, Poels, Stolk, Kenemans, Meyer: "Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas." in: Journal of clinical pathology, Vol. 41, Issue 6, pp. 644-9, (1988) (PubMed).

    Verstijnen, Arends, Moerkerk, Warnaar, Hilgers, Bosman: "CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies." in: Anticancer research, Vol. 6, Issue 1, pp. 97-104, (1986) (PubMed).

  • Target
    CEA (Carcinoembryonic Antigen Gene Family (CEA))
    Andere Bezeichnung
    Carcinoembryonic Antigen / CEA (CEA Produkte)
    Synonyme
    RGD1311281 antikoerper, carcinoembryonic antigen-related cell adhesion molecule 20 antikoerper, carcinoembryonic antigen gene family antikoerper, Ceacam20 antikoerper, Cea antikoerper
    Hintergrund
    This monoclonal antibody is reactive with human carcinoembryonic antigen (CEA), a tumour associated antigen with oncofetal characteristics. Although CEA can be found in tissues of non-neoplastic diseases and normal epithelia, it occurs also in a large variety of carcinomas. Therefore, immunohistochemical detection of CEA is frequently used for the histopathological diagnosis of human tumours.
Sie sind hier:
Kundenservice